What’s New for Biologics | FDA

What’s New for Biologics | FDA

October 25, 2019 Approval Letter - ANTICOAGULANT SODIUM CITRATE 4% w/v SOLUTION, USP

Posted: 10/25/2019

Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile - Agenda

Posted: 10/25/2019

October 24, 2019 Approval Letter - BEXSERO

Posted: 10/25/2019

10/25/2019	October 25, 2019 Approval Letter - ANTICOAGULANT SODIUM CITRATE 4% w/v SOLUTION, USP
10/25/2019	Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile - Agenda
10/25/2019	October 24, 2019 Approval Letter - BEXSERO
10/24/2019	Influenza Vaccine for the 2019-2020 Season
10/24/2019	CBER-Regulated Products: Resolved Shortages
10/21/2019	Clinical Investigator Status (Biologics)
10/17/2019	September 24, 2019 Summary Basis for Regulatory Action - JYNNEOS
10/16/2019	BK190379 - DG Reader Net
10/16/2019	CBER Vacancy: Associate Director for Medical Policy – Title 38(F) Physician (GP-0602-15)
10/16/2019	Submitting Study Datasets for Vaccines to the Office of Vaccines Research and Review: Guidance For Industry; Technical Specifications Document